8 results

• Gilead Settles HIV Drug Lawsuit Over Patent on Truvada and Descovy

  January 20, 2025

  Irvin Jackson

  The U.S. and Gilead have reached a settlement agreement involving patent rights to two HIV drugs, Truvada and Descovy, which are used as pre-exposure prophylaxis treatments to prevent the spread of HIV.

• U.S. Government Files Appeal Over Gilead Truvada, Descovy HIV Drug Patents

  July 10, 2024

  Irvin Jackson

  The U.S. government has asked a federal appeals court to overturn a 2023 jury verdict, which rejected claims that Gilead illegally profited from its patent on certain HIV drugs that the CDC helped the manufacturer develop.

• Lawsuit Over Atripla, Truvada Pay-to-Delay Generics Scheme Results in Defense Verdict for Gilead, Teva

  July 10, 2023

  Irvin Jackson

  Gilead and Teva are not liable for antitrust violations which insurers and other drug purchasers said was a "pay-to-delay" scheme designed to illegally maximize the manufacturers' profits.

• Government’s Gilead HIV Drug Lawsuit Over Patent Rights Ends in Defense Verdict

  May 10, 2023

  Irvin Jackson

  A jury reached a defense verdict on Tuesday in a patent lawsuit filed by the U.S. government over Gilead's HIV drugs.

• Gilead Lawsuit Over Truvada HIV Drug Patents Filed Against U.S. Government

  May 1, 2020

  Irvin Jackson

  Gilead has filed a lawsuit against the U.S. government, claiming it breached multiple contractual agreements by pursuing patents on Truvada during the company's collaboration with the CDC.

• Gilead Quickly Switching Truvada PrEP Users to Descovy Amid Claims It Sat On Safer HIV Drug For Years: Report

  December 9, 2019

  Irvin Jackson

  A new analysis shows Gilead is rapidly convincing Truvada users to switch over to Descovy before the drug goes generic, amid claims it kept the safer drug shelved for years to maximize profits on the more toxic product.

• Government Lawsuit Alleges HIV Drug Maker Gilead Profited Illegally From Taxpayer Research

  November 8, 2019

  Irvin Jackson

  A Justice Department lawsuit accuses Gilead of patent infringement in its sale of Truvada and Descovy as HIV prevention drugs.

• Lawsuit Over Abilify Generic Competition Filed by Otsuka Pharmaceuticals

  September 14, 2016

  Irvin Jackson

  A patent lawsuit has been filed by the makers of Abilify, who say another company is violating its patent by planning to release multiple generic versions of the drug.